Robert I. Blum
Currently, Robert I. Blum holds the position of Chairman of Gamida Cell Ltd. and President, Chief Executive Officer & Director at Cytokinetics, Inc. Mr. Blum is also Member-American Committee at Weizmann Institute of Science.
In his past career Mr. Blum occupied the position of Marketing Director for COR Therapeutics, Inc.
He received an undergraduate degree from Stanford University and an MBA from Harvard Business School.
Transactions
Date
Transaction
Value
| 02/08/2023 | 14,200 | Award at $0 per share. | 0 |
| 02/08/2023 | 28,300 | Award at $0 per share. | 0 |
| 11/18/2022 | 2,000 | Award at $0 per share. | 0 |
| 09/30/2022 | 50,000 | Acquisition at $1.55 per share. | 77,500 |
